Tarsus Pharmaceuticals, Inc.
TARS
43 insider filings · Latest: Jun 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 15 9:38 PM | William Link | Proposed Sale | 10,446 | $81.02 | $846.3K | — | View → |
| Dec 15, 2025 | Dec 15 9:08 PM | WILLIAM J LINK | Proposed Sale | 12,500 | $81.42 | $1.0M | — | View → |
| Sep 24, 2025 | Sep 24 8:57 PM | Bobak Azamian Living Trust | Proposed Sale | 6,000 | $55.37 | $332.2K | — | View → |
| Sep 8, 2025 | Sep 8 8:19 PM | LINK WILLIAM J PHD | Proposed Sale | 27,116 | $57.01 | $1.5M | — | View → |
| Aug 11, 2025 | Aug 11 4:43 PM | Azamian Bobak R. | Proposed Sale | 6,000 | $50.00 | $300.0K | — | View → |
| Jun 17, 2025 | Jun 17 8:14 PM | Farrow Jeffrey S | Proposed Sale | 13,608 | $40.42 | $550.1K | — | View → |
| Jun 16, 2025 | Jun 16 7:07 PM | Lin Elizabeth Yeu | Proposed Sale | 1,006 | $41.07 | $41.3K | — | View → |
| Jun 9, 2025 | Jun 9 2:21 PM | Mottiwala Aziz | Proposed Sale | 17,500 | $44.74 | $783.0K | — | View → |
| Mar 24, 2025 | Mar 24 9:35 PM | Azamian Bobak R. | Proposed Sale | 6,000 | $50.00 | $300.0K | — | View → |
| Mar 20, 2025 | Mar 20 8:35 PM | Whitfield Dianne C. | Proposed Sale | 2,137 | $50.11 | $107.1K | — | View → |
| Mar 20, 2025 | Mar 20 8:30 PM | Farrow Jeffrey S | Proposed Sale | 1,186 | $50.11 | $59.4K | — | View → |
| Mar 20, 2025 | Mar 20 8:29 PM | Mottiwala Aziz | Proposed Sale | 3,365 | $50.11 | $168.6K | — | View → |
| Mar 20, 2025 | Mar 20 8:21 PM | Wahl Bryan | Proposed Sale | 3,084 | $50.11 | $154.6K | — | View → |
| Mar 20, 2025 | Mar 20 8:18 PM | Neervannan Seshadri | Proposed Sale | 2,435 | $50.11 | $122.0K | — | View → |
| Mar 20, 2025 | Mar 20 8:11 PM | Azamian Bobak R. | Proposed Sale | 8,534 | $50.11 | $427.7K | — | View → |
| Mar 19, 2025 | Mar 19 7:27 PM | Neervannan Seshadri | Proposed Sale | 2,543 | $47.40 | $120.5K | — | View → |
| Mar 19, 2025 | Mar 19 7:24 PM | Wahl Bryan | Proposed Sale | 3,261 | $47.40 | $154.6K | — | View → |
| Mar 19, 2025 | Mar 19 7:23 PM | Azamian Bobak R. | Proposed Sale | 8,551 | $47.40 | $405.3K | — | View → |
| Mar 19, 2025 | Mar 19 7:22 PM | Whitfield Dianne C. | Proposed Sale | 2,259 | $47.40 | $107.1K | — | View → |
| Mar 19, 2025 | Mar 19 7:12 PM | Farrow Jeffrey S | Proposed Sale | 1,254 | $47.40 | $59.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:24 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Option Exercise | 66,274 | — | 44,634(D) | View → |
| Mar 15, 2026 | Mar 17 8:20 PM | Elizabeth Yeu LinChief Medical Officer | Option Exercise | 2,511 | — | 7,534(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bryan WahlGeneral Counsel | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Aziz MottiwalaChief Commercial Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Seshadri NeervannanChief Operating Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Dianne C. WhitfieldChief Human Resources Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Elizabeth Yeu LinChief Medical Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Grant/Award | 157,499 | $74.90 | 60,776(D) | View → |
| Feb 18, 2026 | Feb 20 9:35 PM | I E Pyott DavidDirector | Grant/Award | 9,622 | $63.27 | 3,729(D) | View → |
← Previous
Page 2 of 2